Prodigiosenes, possessing a 4-methoxypyrrolyldipyrrin skeleton, are known for their anti-cancer activity. Structural modification of the C-ring resulted in a series of prodigiosenes that displayed promising activity against leukemia cell lines during in vitro analysis against the NCI 60 cancer cell line panel. Further in vivo studies of these compounds using the zebrafish model showed persistence of anti-leukemia properties in human K562 chronic myelogenous leukemia cells.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c2ob26535d | DOI Listing |
Publication Analysis
Top Keywords
investigations utility
4
utility prodigiosenes
4
prodigiosenes treat
4
treat leukemia
4
leukemia prodigiosenes
4
prodigiosenes possessing
4
possessing 4-methoxypyrrolyldipyrrin
4
4-methoxypyrrolyldipyrrin skeleton
4
skeleton anti-cancer
4
anti-cancer activity
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!